Ovarian cancer screening: Current status and future directions
نویسندگان
چکیده
منابع مشابه
Ovarian cancer screening—Current status, future directions☆
Evidence of a mortality benefit continues to elude ovarian cancer (OC) screening. Data from the US Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial which used a screening strategy incorporating CA125 cut-off and transvaginal ultrasound has not shown mortality benefit. The United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) is using the Risk of Ovarian Ca...
متن کاملCurrent Status and Future Directions
Myocardial deformation imaging is a novel echocardiographic method for assessment of global and regional myocardial function. As this technology has evolved, it has been applied to an increasing number of research questions, and the number of publications incorporating deformation imaging has grown in parallel. Although not yet sufficiently vetted for routine clinical use, these methods offer t...
متن کاملCurrent and future directions of clinical trials for ovarian cancer.
BACKGROUND The management of ovarian cancer includes a combination of surgery and chemotherapy. The majority of clinical trials have historically addressed questions pertaining to the selection, dosing, and schedule of chemotherapy agents. METHODS In this report, a comprehensive review of the major clinical trials in ovarian cancer is performed. The increasing data and clinical experience in ...
متن کاملHoney and Cancer: Current Status and Future Directions
Cancer is a leading cause of death worldwide and poses a challenge to treatment. With overwhelming evidence of the role played by diet and lifestyle in cancer risk and prevention, there is a growing interest into the search for chemopreventative or chemotherapeutic agents derived from natural products. Honey is an important source of bioactive compounds derived from plants and recent years have...
متن کاملLung cancer screening: history, current perspectives, and future directions
Lung cancer has remained the leading cause of death worldwide among all cancers. The dismal 5-year survival rate of 16% is in part due to the lack of symptoms during early stages and lack of an effective screening test until recently. Chest X-ray and sputum cytology were studied extensively as potential screening tests for lung cancer and were conclusively proven to be of no value. Subsequently...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Best Practice & Research Clinical Obstetrics & Gynaecology
سال: 2020
ISSN: 1521-6934
DOI: 10.1016/j.bpobgyn.2020.02.010